Oramed Pharmaceuticals
ORMP
ORMP
22 hedge funds and large institutions have $13.7M invested in Oramed Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
62% less call options, than puts
Call options by funds: $211K | Put options by funds: $557K
Holders
22
Holding in Top 10
–
Calls
$211K
Puts
$557K
Top Buyers
| 1 | +$1.56M | |
| 2 | +$212K | |
| 3 | +$164K | |
| 4 |
GIM
Greylin Investment Management
Orange,
Virginia
|
+$60.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$41.4K |
Top Sellers
| 1 | -$528K | |
| 2 | -$176K | |
| 3 | -$142K | |
| 4 |
Morgan Stanley
New York
|
-$125K |
| 5 |
Barclays
London,
United Kingdom
|
-$121K |